Skip To Main Content
Eystein Sverre Husebye on Muck Rack

Eystein Sverre Husebye

As seen in: PLOS, BioRxiv, Tidsskrift
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Eystein Sverre

Contact Eystein Sverre, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Cushings sykdom i Helse Vest

|
By Kristian Løvås, Morten Lund-Johansen, Eystein Sverre Husebye, Ingrid Martinsen Amland
| Tidsskrift
Main findings Hovedfunn Estimert insidens av Cushings sykdom i Helse Vest i perioden 1.1.2010 til 31.12.2022 var 3,0 per million innbyggere per år. 33 av 42 pasienter hadde én eller flere metabolske sykdommer på diagnosetidspunktet. Alle pasientene gjennomgikk hypofysekirurgi som førstelinjebehandling. Ved studieslutt eller død var 20 av 42 pasienter i remisjon etter hypofysekirurgi og/eller gammaknivbehandling.
Open in Who Shared Issue with article?

High-Resolution Transcriptional Impact of AIRE: Effects of Pathogenic Variants p.Arg257Ter, p.Cys311Tyr, and Polygenic Risk Variant p.Arg471Cys

|
By Bergithe Eikeland Oftedal, Eystein Sverre Husebye, Per Morten Knappskog, Eirik Bratland
| BioRxiv
Abstract The Autoimmune Regulator, AIRE, acts as a transcriptional regulator in the thymus, facilitating ectopic expression of thousands of genes important for the process of negative T-cell selection and immunological tolerance to self. Pathogenic variants in the gene encoding AIRE are causing Autoimmune polyendocrine syndrome type 1 (APS-1), defined by multiorgan autoimmunity and chronic mucocutaneous candidiasis.
Open in Who Shared Issue with article?

Fear of Covid 19 during the third wave of infection in Norwegian patients with type 1 diabetes

|
By Grethe Åstrøm Ueland, Tony Ernes, Tone Vonheim Madsen, Eystein Sverre Husebye
| PLOS
Loading metrics Open Access Peer-reviewed Research Article Abstract Objective To study the fear of Covid 19 infection among Norwegian patients with type 1 diabetes. Research design and methods Fear of Covid 19 scale, a validated scale assessing the fear of Covid 19, was sent electronically to 16255 patients with type 1 diabetes in May 2021. The items are rated on a scale from 1 to 5 (total scores from 7 to 35). The higher the score, the greater the fear.
Open in Who Shared Issue with article?
See all 3 articles